(Q78488897)
Statements
Cutting edge: CD4+CD25+ alloantigen-specific immunoregulatory cells that can prevent CD8+ T cell-mediated graft rejection: implications for anti-CD154 immunotherapy (English)
Andre van van Maurik
Manuela Herber
Kathryn J Wood
1 November 2002